The logic behind this concept is that concentrations of NPs decrease following institution or intensification of several established therapies of HF; among these agents are diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB), β blockers, spironolactone, and nesiritide [29-52]. This evidence concerns the gene ACE and hydrops fetalis.